China Net Finance, August 30, at the “China Jinggangshan Eucommia Research and Application Conference” on the 29th, the “China Eucommia Industry Development Report (2019 Edition)” and “Eucommia Research” were released.
Academician Huang Luqi, academician of the Chinese Academy of Engineering, member of the Standing Committee of the National Committee of the Chinese People’s Political Consultative Conference, president of the Chinese Academy of Chinese Medical Sciences, and president of the Chinese Medicine Association, sent congratulations to the conference via video. He said that Eucommia ulmoides is a very important national strategic resource unique to my country. The eucommia ulmoides industry is a compound industry with a wide range of coverage, a long industrial chain and a wide variety of products. It is maintaining national ecological security, inheriting and developing traditional Chinese medicine, and meeting people’s health needs. It plays an important role in driving farmers’ income and other aspects. “In the field of general health, the Eucommia ulmoides industry can be made into the same big industry as ginseng and Panax notoginseng. Therefore, the comprehensive development and utilization of eucommia ulmoides can be used as an important choice for the biomedical industry and ecological agriculture.”
Hu Shizhong, deputy director of the Standing Committee of the Jiangxi Provincial People’s Congress and Secretary of the Ji’an Municipal Party Committee, stated that Ji’an is one of the main distribution areas of Eucommia ulmoides in Jiangxi. He said that relying on leading companies such as Tuopuzheng Pharmaceutical, the eucommia ulmoides industry has gathered the exclusive Chinese national medicine quasi-national medical insurance drugs Quandu Capsules, eucommia granules health products, eucommia leaf tea, etc., and are improving technology, quality and standards to improve Jinggang Eucommia has become a beautiful brand in the city’s biomedical health industry. On the same day, the China Chamber of Commerce for Import and Export of Medicines and Health Products and the Institute of Medicinal Plants of the Chinese Academy of Medical Sciences respectively held a signing ceremony for large-scale health technology consulting cooperation with the National Jinggangshan Economic Development Zone and the Ji’an Municipal Health Commission.
On the same day, the conference held three “Eucommia ulmoides clinical value development and application academic exchange meeting”, “Eucommia ulmoides industry technology standard exchange meeting”, and “Chinese medicine industry development exchange meeting (Huatuo project charity trip Ji’an Chinese medicine industry training)”. At the branch venue, Professor Wu Zonggui of the Changzheng Hospital Affiliated to Naval Military Medical University, Major General Wu Zonggui, Professor Tu Pengfei of Peking University Modern Chinese Medicine Research Center, Secretary General of Chinese Medicine Branch, Director of the Institute of Medicinal Plants, Chinese Academy of Medical Sciences and other 20 experts did wonderful academic work Communication report.
This conference is sponsored by China Association of Chinese Materia Medica, China Chamber of Commerce for Import and Export of Medicines and Health Products, Chinese Medicine Branch of China Association for the Promotion of International Exchanges in Health Care; organized by Ji’an Municipal People’s Government and Jiangxi Provincial Administration of Traditional Chinese Medicine; China Association of Chinese Materia Medica and Eucommia Professional Committee , Jinggangshan Economic and Technological Development Zone Management Committee, Ji’an Municipal Party Committee Talent Office, Ji’an City Industry and Information Technology Bureau, Ji’an City Health Commission, and Puzheng Pharmaceutical Group Co., Ltd.